Real-World Outcomes of Adjuvant Paclitaxel and Trastuzumab Therapy in Lymph Node-Negative, HER2-Positive Early-Stage Breast Cancer: A Multicenter Retrospective Data Analysis
- DOI
- 10.3390/cancers17142271
- Published
- 2025-07-08
- Container
- Cancers
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/cancers17142271,
title = {Real-World Outcomes of Adjuvant Paclitaxel and Trastuzumab Therapy in Lymph Node-Negative, HER2-Positive Early-Stage Breast Cancer: A Multicenter Retrospective Data Analysis},
author = {Buket Şahin Çelik and Pınar Peker and Ender Eren Özçelik and Ömer Faruk Kuzu and Erhan Gökmen and Gül Başaran and Türkkan Evrensel},
year = {2025},
journal = {Cancers},
doi = {10.3390/cancers17142271},
url = {https://doi.org/10.3390/cancers17142271}
}RIS
TY - JOUR TI - Real-World Outcomes of Adjuvant Paclitaxel and Trastuzumab Therapy in Lymph Node-Negative, HER2-Positive Early-Stage Breast Cancer: A Multicenter Retrospective Data Analysis AU - Buket Şahin Çelik AU - Pınar Peker AU - Ender Eren Özçelik AU - Ömer Faruk Kuzu AU - Erhan Gökmen AU - Gül Başaran AU - Türkkan Evrensel PY - 2025 JO - Cancers DO - 10.3390/cancers17142271 UR - https://doi.org/10.3390/cancers17142271 ER -
APA
Çelik, B. Ş., Peker, P., Özçelik, E. E., Kuzu, Ö. F., Gökmen, E., Başaran, G., & Evrensel, T. (2025). Real-World Outcomes of Adjuvant Paclitaxel and Trastuzumab Therapy in Lymph Node-Negative, HER2-Positive Early-Stage Breast Cancer: A Multicenter Retrospective Data Analysis. Cancers. https://doi.org/10.3390/cancers17142271
Source records
- crossref · retrieved 2026-09-27T16:29:03.751Z